COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring. |
Microglial states and nomenclatureAdd to your list(s) Download to your calendar using vCal
If you have a question about this talk, please contact Timothy Birkle. Microglial research has advanced considerably in recent decades yet has been constrained by a rolling series of dichotomies such as “resting versus activated” and “M1 versus M2”. This dualistic classification of good or bad microglia is inconsistent with the wide repertoire of microglial states and functions in development, plasticity, aging and diseases that were elucidated in recent years. New designations continuously arising in an attempt to describe the different microglial states, notably defined using transcriptomics and proteomics, may easily lead to a misleading, although unintentional, coupling of categories and functions. To address these issues, we assembled a group of multidisciplinary experts to discuss our current understanding of microglial states as a dynamic concept and the importance of addressing microglial function. Here, we provide a conceptual framework and recommendations on the use of microglial nomenclature for researchers, reviewers, and editors, which will serve as the foundations for a future white paper This talk is part of the Microglia webinar series series. This talk is included in these lists:
Note that ex-directory lists are not shown. |
Other listsHadoop Future Scope Type the title of a new list hereOther talksExploring terminal duct lobular unit (TDLU) development using non-traditional models Liquid interface and buoyancy stabilization using high-frequency vibrations Data-driven structural assessment The Parkinson’s disease protein LRRK2 regulates the transition from innate to adaptive immunity by modulating the unfolded protein response Extreme events, tail statistics, and large deviation theory in fluid flows CD4+ T cell memory during type 1 immune response |